French National Registry of Rare Peritoneal Surface Malignancies
- Conditions
- Pseudomyxoma PeritoneiPrimary Peritoneal Serous CarcinomaDiffuse Peritoneal LeiomyomatosisAppendiceal Mucinous NeoplasmsPeritoneal MesotheliomaPsammocarcinomaRare Peritoneal Surface MalignanciesDesmoplastic Small Round Cell Tumor
- Interventions
- Other: Non interventional
- Registration Number
- NCT02834169
- Lead Sponsor
- Hospices Civils de Lyon
- Brief Summary
Despite advances in the management of and changes in clinical practice, little is known about the epidemiology, patterns of care and outcomes of rare peritoneal surface malignancies patients in France.
In order to better understand the characteristics of rare peritoneal surface malignancies and to evaluate treatment strategies, the RENAPE registry aims at the collection of data from patients presenting with a rare peritoneal surface malignancy in France. Data will be entered prospectively in a specifically designed and secured web database.
All RENAPE's centres and physicians are invited to register patients with a rare peritoneal surface malignancy diagnosis and to participate to the registry. Data will be evaluated within regular time frames, focusing on types of rare peritoneal surface malignancies, treatment modalities and patient outcomes (e.g. survival, recurrence), thereby contributing to the better understanding of these rare cancers.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 2171
- Patients are eligible if they have a histologically proven rare peritoneal surface malignancy.
- Histological diagnostic of peritoneal surface malignancy not confirmed
- Expected clinical follow up data not available
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description primary peritoneal serous carcinoma Non interventional Data from primary peritoneal serous carcinoma cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease). pseudomyxoma peritonei Non interventional Data from pseudomyxoma peritonei cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease). peritoneal mesothelioma Non interventional Data from peritoneal mesothelioma cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease). desmoplastic small round cell tumor Non interventional Data from desmoplastic small round cell tumor cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease). psammocarcinoma Non interventional Data from primary peritoneal serous carcinoma cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease). diffuse peritoneal leiomyomatosis Non interventional Data from diffuse peritoneal leiomyomatosis cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease). appendiceal mucinous neoplasms Non interventional Data from appendiceal mucinous neoplasms cases will be used to generate descriptive statistics on demographics, clinical characteristics including prevalence and incidence of co-morbidities, treatment patterns, and patient outcomes (resulting from treatment or disease).
- Primary Outcome Measures
Name Time Method Incidence of rare peritoneal surface malignancies year 5 Collect detailed clinical and histological diagnosis for estimating annual incidence rate
- Secondary Outcome Measures
Name Time Method Impact of specific treatment strategies year 5 Collect detailed therapeutic strategies (surgical procedure, chemotherapy, etc.) on patients with rare peritoneal surface malignancies
Trial Locations
- Locations (33)
CHU Jean Minjoz
🇫🇷Besancon, France
Institut Bergonié
🇫🇷Bordeaux, France
Centre François Baclesse
🇫🇷Caen, France
Institut de Cancérologie de l'Ouest - Paul Papin
🇫🇷Angers, France
CHU Estaing
🇫🇷Clermont-ferrand, France
CHU Bocage
🇫🇷Dijon, France
Centre Jean Perrin
🇫🇷Clermont-ferrand, France
CHRU Claude Huriez
🇫🇷Lille, France
Centre Léon Bérard
🇫🇷Lyon, France
AP-HP Louis MOURIER
🇫🇷Colombes, France
CHU A. Michallon
🇫🇷La Tronche, France
Centre Oscar Lambret
🇫🇷Lille, France
Institut Paoli Calmettes
🇫🇷Marseille, France
Hôpital La Timône
🇫🇷Marseille, France
Institut du Cancer Montpellier
🇫🇷Montpellier, France
CHU Nantes Hôtel-Dieu
🇫🇷Nantes, France
CHU L'Archet II
🇫🇷Nice, France
AP-HP Lariboisière
🇫🇷Paris Cedex 10, France
AP-HP St Antoine
🇫🇷Paris, France
CHU Poitiers
🇫🇷Poitiers, France
Institut Curie
🇫🇷Paris, France
AP-HP La Pitié-Salpêtrière
🇫🇷Paris, France
Hospices Civils de Lyon - Centre Hospitalier Lyon Sud - Service de Chirurgie Générale et Digestive - 165 chemin du grand Revoyet,
🇫🇷Pierre-benite, France
Hôpital Robert Debré
🇫🇷Reims, France
CHU Charles Nicolle
🇫🇷Rouen, France
CHU Nord
🇫🇷St Etienne, France
CHRU Hautepierre
🇫🇷Strasbourg, France
Hôpital Purpan
🇫🇷Toulouse, France
Institut Claudius Regaud
🇫🇷Toulouse, France
Institut de Cancérologie de Lorraine
🇫🇷Vandoeuvre-les-nancy, France
Institut Gustave Roussy
🇫🇷Villejuif, France
AP-HP Hôpîtal Europeen Georges Pompidou
🇫🇷Paris Cedex 15, France
Institut Cancérologie de l'Ouest - René Gauducheau
🇫🇷Saint Herblain, France